Tiny Health, a pioneer in at-home microbiome testing for babies and families, announces the addition of two esteemed ...

RIYADH, Saudi Arabia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is ...

Humber River Health (Humber) is pleased to have ranked among the top five Ontario hospitals for every category of the American College of Surgeons’ (ACS) 2023 National Surgical Quality Improvement ...

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that ...

Year-to-date as of September 2024, QHSLab’s platform has processed approximately 50,000 assessments, more than doubling the number of assessments completed during the same period last year. This ...

The specialty care platform formerly known as Employer Direct Healthcare (EDH) has become Lantern, and the company is announcing its newest product offering – Infusion Care. Lantern is also expanding ...

“Accumulus Synergy is a catalyst for change. Leading with purpose and vision, Accumulus is not merely innovating but pioneering an industry paradigm shift for regulatory harmonization and digital ...

MCKINNEY, Texas and FRISCO, Texas, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stonebriar Facial and Oral Surgery, an oral and maxillofacial surgery (OMS) practice in Frisco, Texas, will open a new location in ...

The abstract will be available on the ESMO® Asia Congress website on Sunday, Dec. 1, 2024 at 11:05 a.m. ET. The full presentation will be available on the Merus website at the start of each session.

Assessment by specialist AI team from “PersonalAIze” Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform AMSTERDAM, Sept. 17, 2024 ...

MINNEAPOLIS, MN, Sept. 17, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today announced it has completed the acquisition of the second revenue-generating ...

BOSTON, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel ...